MDAnywhere

Telehealth on the prescription side has a settled top tier. Teladoc, MDLive, and Hims run in all 50 states, have years of patient volume behind them, and carry a public record deep enough that a prospective patient can read about prescription delays, refund fights, and the awkward edge cases before handing over a card. MDAnywhere asks to be measured against that and arrives with less of everything: a shorter history since 2019 under MDAnywhere.com LLC, a 32-state map, and a ratings picture that looks flawless in a way flawless rarely is.

Rating patterns across multiple platforms

Six platforms carry a score, and the spread rewards reading over averaging. Trustpilot puts MDAnywhere at 5 stars, the Canadian-facing page drawing on well over a thousand reviewers, and that lone figure is the only sample large enough to mean much. The rest are dozens deep. RealReviews.io gives 5 stars from 36 reviews. Trustrecap scores 5.0 from 40 reviewers. Knoji lands at 4.0 out of five across 38 reviews. The Apple App Store keeps its own pool. The BBB grades MDAnywhere.com LLC an A+ with accreditation, individual complaints filed against that grade, which is ordinary for any service writing real prescriptions at scale.

Where friction appears in reviews

The glossy headline buries the two most informative entries. Knoji's 4.0 and the BBB complaints are the only places friction shows. Everywhere else is a wall of perfect fives across small platforms, which is exactly the pattern a little coordination buys. A patient who reads the Trustpilot total and stops is reading the marketing.

Pricing model and service conditions

The no-treatment, no-charge policy is the one structural break from rivals that bill a flat visit fee whatever the outcome. Visits start at $29 with no subscription. The condition list runs wide for a telehealth shop this size: UTIs, yeast infections, sinus infections, cold sores, erectile dysfunction, asthma medication, prescription refills covering anxiety medications and maintenance renewals, lab tests, TB screening, heart health and food allergy testing, vaccine orders, a Wegovy weight-loss track, cosmetic treatments, and dedicated women's and men's health sections. Travel packs and doctor's notes for work or school round it out. Physician review runs 7am to 1am EST daily.

Asynchronous care and its limitations

A caveat is baked into the model. The iOS app sits on the Apple App Store, and care is asynchronous and questionnaire-driven from start to finish, so no physical examination happens. Anything needing hands-on assessment gets declined, and the no-charge policy covers that decline. More honest than paying upfront and learning the limits later.

State availability determines access

Geography is where the listing stops working for a large share of readers. Wisp, the closest named competitor across the overlapping sexual-health and women's-health categories, covers all 50 states. For anyone living outside MDAnywhere's 32, the broad condition list and the clever pricing are beside the point, because the service cannot legally reach them. Inside those 32, the picture flips. The breadth across respiratory, metabolic, travel medicine, and lab-test categories runs past what Wisp offers. So the whole question turns on one fact the patient already knows about themselves: their state. No consultation settles that. The published map does, the moment they look.

Contact methods for patient support

A toll-free phone number is published. A mailing address, a New York PO box pulled from the BBB profile, gives the operation a physical anchor a patient could write to. A contact form sits on the site. For a remote prescriber with no clinics, that is the right minimum, and MDAnywhere clears it.

Strip away the headline and what is left is honest enough on its own terms. The pricing is unusual in a useful direction. The conditions are laid out as actual lists, not gestures. The contact trail holds. The evidence, though, never gets past its own shape: one large rating pool wrapped around five small ones, all near-perfect, against competitors with longer histories and full national coverage. Inside the 32 states, a patient whose specific need maps onto that list can risk $29 on terms that cost nothing if the visit fails, and that is a defensible bet without anyone needing to be talked into it. Outside the 32, none of it applies. Wisp and MDLive both reach where MDAnywhere cannot, and the state line is the entire decision before pricing, breadth, or ratings ever enter it.